Pulmonary Embolism and Thrombosis Clinical Trials

8 recruitingLast updated: June 17, 2026

There are 8 actively recruiting pulmonary embolism and thrombosis clinical trials across 5 countries. Studies span Not Applicable, Early Phase 1. Top locations include Shenyang, Liaoning, China, Madrid, Madrid, Spain, Murray, Utah, United States. Updated daily from ClinicalTrials.gov.


Pulmonary Embolism and Thrombosis Trials at a Glance

8 actively recruiting trials for pulmonary embolism and thrombosis are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Shenyang, Madrid, and Murray. Lead sponsors running pulmonary embolism and thrombosis studies include Shengjing Hospital, Rushad Patell, and Instituto de Investigacion Sanitaria La Fe.

Browse pulmonary embolism and thrombosis trials by phase

Treatments under study

About Pulmonary Embolism and Thrombosis Clinical Trials

Looking for clinical trials for Pulmonary Embolism and Thrombosis? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pulmonary Embolism and Thrombosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pulmonary Embolism and Thrombosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Thrombectomy in PE

Pulmonary Embolism and Thrombosis
University Hospital Plymouth NHS Trust2,000 enrolled1 locationNCT07650435
Recruiting
Not Applicable

Assessment of Pulmonary Perfusion and Hemodynamic Measurements by Electrical Impedance Tomography in Patients Undergoing Pulmonary Thromboendarterectomy.

Pulmonary Embolism and ThrombosisPulmonary Thromboendarterectomy
University of Sao Paulo General Hospital36 enrolled1 locationNCT07577700
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

Pulmonary Embolism and ThrombosisDeterioration, Clinical
Shengjing Hospital300 enrolled1 locationNCT05098769
Recruiting

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Artificial IntelligencePulmonary Embolism and ThrombosisDeterioration, Clinical
Shengjing Hospital2,000 enrolled1 locationNCT05482269
Recruiting

Registry of Catheter Intervention in Pulmonary Embolism

Pulmonary EmbolismPulmonary ThromboembolismsPulmonary Embolism and Thrombosis+2 more
Hospital San Carlos, Madrid300 enrolled1 locationNCT06348459
Recruiting
Not Applicable

Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy Vs. Thromboaspiration.

Pulmonary Embolism and Thrombosis
Instituto de Investigacion Sanitaria La Fe60 enrolled1 locationNCT06051032
Recruiting
Not Applicable

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Venous Thromboembolic DiseaseDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Scott C. Woller, MD152,000 enrolled1 locationNCT06232551